MARC record from Internet Archive

LEADER: 03295cam 2200721 a 4500
001 ocm07533426
003 OCoLC
005 20220511215118.0
008 811210s1981 enka b 100 0 eng
010 $a 80041953
040 $aDLC$beng$cDLC$dUKM$dMUQ$dOCLCQ$dBTCTA$dOCLCG$dBDX$dGBVCP$dOCLCO$dOCLCQ$dTPH$dOCLCO$dOCLCQ$dOCLCO$dOCLCQ$dOCLCO$dBUF$dKIJ$dOCLCF$dGZH$dDCHUA$dOCLCO$dOCLCQ$dOCLCO
019 $a7651448$a16550801
020 $a0808913689$q(Grune & Stratton ;$qpbk.)
020 $a9780808913689$q(Grune & Stratton ;$qpbk.)
020 $a0127917438$q(pbk.)
020 $a9780127917436$q(pbk.)
035 $a(OCoLC)7533426$z(OCoLC)7651448$z(OCoLC)16550801
050 00 $aRM666.N32$bI57
060 4 $aQV150$bGRO
082 00 $a615/.71$219
084 $a44.38$2bcl
245 00 $aInternational experience with nadolol :$ba long-acting B-blocking agent /$cedited by F. Gross.
264 1 $aLondon :$bRoyal Society of Medicine ;$aNew York :$bGrune & Stratton,$c1981.
300 $axiv, 229 pages :$billustrations ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
490 1 $aInternational congress and symposium series,$x0142-2367 ;$vno. 37
500 $a"Proceedings of a symposium held by Squibb Europe Limited at the Grand Hotel, Paris, on 5, 6, and 7 December 1980"--Half title page
504 $aIncludes bibliographical references.
650 0 $aNadolol$xPhysiological effect$vCongresses.
650 0 $aBlood circulation disorders$xChemotherapy$vCongresses.
650 0 $aHypertension$xChemotherapy$vCongresses.
650 0 $aAdrenergic beta blockers.
650 0 $aNadolol$xPhysiological effect$xCongresses.
650 0 $aBlood circulation disorders$xChemotherapy$xCongresses.
650 2 $aAdrenergic beta-Antagonists
650 2 $aCardiovascular Diseases$xdrug therapy
650 6 $aNadolol$xEffets physiologiques$xCongrès.
650 6 $aSang$xTroubles de la circulation$xChimiothérapie$xCongrès.
650 6 $aHypertension artérielle$xChimiothérapie$vCongrès.
650 6 $aNadolol$xEffets physiologiques$vCongrès.
650 6 $aSang$xTroubles de la circulation$xChimiothérapie$vCongrès.
650 6 $aBêtabloquants.
650 7 $aHypertension$xChemotherapy.$2fast$0(OCoLC)fst00965835
650 7 $aNadolol$xPhysiological effect.$2fast$0(OCoLC)fst01032140
653 $aMedicine$aDrug therapy$aNadolol - Conference proceedings
655 2 $aCongress
655 7 $aConference papers and proceedings.$2fast$0(OCoLC)fst01423772
655 7 $aConference papers and proceedings.$2lcgft
655 7 $aActes de congrès.$2rvmgf
700 1 $aGross, F. H.$q(Franz Heinrich)
710 2 $aSquibb Europe Limited.
776 08 $iOnline version:$tInternational experience with nadolol.$dLondon : Royal Society of Medicine ; New York : Grune & Stratton, 1981$w(OCoLC)565629511
830 0 $aInternational congress and symposium series ;$vno. 37.$x0142-2367
938 $aBrodart$bBROD$n32557493$c$38.50
938 $aBaker and Taylor$bBTCP$n80041953
029 1 $aAU@$b000002080286
029 1 $aGBVCP$b012551724
029 1 $aGBVCP$b016198239
029 1 $aNZ1$b12994181
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 68 OTHER HOLDINGS